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Abstract
Background: Adverse drug reactions (ADRs) present a challenging and expensive public health problem. Polypharmacy is
defined according to the WHO criteria as the, ‘‘concurrent use of five or more different prescription medication’’. Elderly are
more prone to adverse reactions due to comorbid conditions, longer lists of medications and sensitivity to drug effects. The
aim of the study is to estimate the incidence and strength of association of ADRs due to polypharmacy among the geriatric
cohort attending outpatient clinics at a tertiary care center.
Methods: A hospital based prospective cohort study was conducted at ambulatory care clinics of Aga Khan University
Hospital April 2012 to March 2013. One thousand geriatrics patients (age $65 years) visiting ambulatory clinics were
identified. They were divided on the basis of exposure (polypharmacy vs. no polypharmacy). We followed them from the
time of their enrollment (day zero) to six weeks, checking up on them once a week. Incidence was calculated and Cox
Proportional Hazard Model estimates were used.
Results: The final analysis was performed on 1000 elderly patients. The occurrence of polypharmacy was 70% and the
incidence of ADRs was 10.5% among the study cohort. The majority (30%) of patients were unable to read or write. The use
of herbal medicine was reported by 3.2% of the patients and homeopathic by 3%. Our Cox adjusted model shows that
polypharmacy was 2.3 times more associated with ADRs, con-current complementary and alternative medicine (CAM) was
7.4 times and those who cannot read and write were 1.5 times more associated with ADRs.
Conclusion: The incidence of ADRs due to poly pharmacy is alarmingly high. The factors associated with ADRs are
modifiable. Policies are needed to design and strengthen the prescription pattern.
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According to WHO, polypharmacy is defined as the concurrent
use of five or more different prescription medications. Previous
studies have provided evidence that the probability of ADRs
among geriatric patients is estimated at 6% when two drugs are
taken, increases to 50% when five drugs are taken, and becomes
100% when eight or more drugs are taken simultaneously [6].
Polypharmacy has also been documented as a major risk factor for
ADRs in the developed countries [7]. Ageing has a strong impact
on the pharmacokinetics and pharmacodynamics, comorbidity,
and patterns of medication that may contribute to an increased
risk of adverse events. A study from Malaysia found higher
incidence of polypharmacy among geriatric inpatients (62.8%) on
admission and it was associated with the high prevalence of
cardiovascular diseases and diabetes mellitus [8].

Background
Epidemiologic transition over the years has increased the
percentage of elderly (aged greater than 65 years). The elderly
people now constitute more than 60% of the world population,
which in turn increases their hospital visits leading to multiple
medications’ use [1]. Approximately there are 841 million elderly
(60 years and older) people in the world. By 2050, nearly 8 in 10 of
the world’s older population will be living in the less developed
areas [2]. This increase in life expectancy has brought about
increased numbers of certain chronic illnesses, which involves
hospital admissions, multiple medications and its associated ADR’s
[3]. Inappropriate use of medicines is one of the challenges of the
public health domain and may lead to serious (ADRs) [4]that
account for 3% to 23% of hospital admissions, prolong hospital
stays, and increase in morbidity and mortality [5].
PLOS ONE | www.plosone.org
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was performed before labeling any case as an ADR [15]. Besides
this, the standard ADR Reporting Form by the drug and poison
information center at the Department of Pharmacy Services,
AKU, was also used to record all the essential information
regarding the adverse effects: suspected drugs, suspected reaction,
date of onset, date when the adverse effects ceased and severity of
the ADR experienced (fatal, non-fatal). Subjects with ADRs were
formally referred to their primary investigators.

Few epidemiological studies investigating the role of polypharmacy among the geriatrics have been almost exclusively conducted
in the developed countries [9,10]. However, there is a scarcity of
evidence from Asian countries including Pakistan, and prospective
studies investigating the association between polypharmacy and
ADRs are almost lacking [11,12]. Hence, determining the true
incidence along with strength of association of ADRs due to
polypharmacy among geriatrics would help in designing guidelines
and policies for this vulnerable population. We hypothesize that
the risk of ADRs among the exposed (polypharmacy) was greater
than that of the un-exposed group. The overall aims of the study
were to estimate the incidence of ADRs and its association with
polypharmacy among the geriatric cohort attending outpatient
clinics at a tertiary care center in Karachi, Pakistan.

Drug characteristics by Anatomical Therapeutic Chemical
Drugs involved in the ADRs were coded into various drug
classes according to Anatomical Therapeutic Chemical (ATC)
classification based on WHO-ATC Index 2005 [16]. In the ATC
classification system, the drugs are divided into different groups
according to the organ or system on which they act and their
chemical, pharmacological and therapeutic properties.

Methods
Study Design and Population

Covariables

A prospective cohort study was conducted during April 2012 to
March 2013 at Aga Khan University Hospital (AKUH) Karachi,
Pakistan, a 563 bedded, Join Commission International (JCI)
accredited tertiary care center providing state of the art health care
facilities. The study recruited a cohort of 1000 geriatrics patients
having age $65 years, using consecutive sampling technique,
either male or female at their index visit to any sub-specialty
ambulatory care clinics (Family Medicine, Medicine, Surgery,
Obstetrics and Gynecology) and was followed for six weeks to
collect relevant factual data for the incidence of ADRs due to
polypharmacy. Figure 1 shows the flow of participant in the
study. Subjects who were transferred to inpatient departments
directly from clinic or those who required hospital admission or
known to be mentally disabled or were suffering from advanced
neurological diseases like dementia or acute confusion were not
recruited. Written informed consent was obtained from each
participant at the time of recruitment, those who were not able to
read or write, detailed explanation was provided about the study
protocol by the data collector and thumb impression was obtained
in presence of a family member.
Ethics Statement. Ethical approval for this study was
obtained from the ethical review committee of Aga Khan
University (AKU FWA 00001177).

Covariables were collected from administrative questionnaires
at baseline. Covariables included age (65–70, 71–80 and .80
years), sex, educational status (Can’t Read or Write, #5, 6–14,
and .14 years of education), occupational status (unemployed/
retired, employed), polypharmacy (no, yes), medication data with
dose, frequency and duration, frequency of dose missing (no, yes)
and non-prescription drugs (herbal, homeopathic, over the
counter).

Statistical Methods
The sample size was calculated by taking into account the
objectives of the study. We used Epi Info Version 6 to calculate the
sample size. The calculations were based on the assumption that
polypharmacy among the Pakistani geriatrics is 50% (as we do not
have any information regarding these in our community). By
taking into account all of these figures together with 99%
confidence interval, and exposed to non-exposed ratio of 1:1 with
90% power and risk ratio of 1.3, the sample size came out to be
n = 750. After adjusting 30% for non -responders the final
required sample size was approximately 1000 geriatric participants.
In the analysis of cohort of 1000 geriatrics, we evaluated
polypharmacy at baseline and cumulative incidence of ADRs, in
relation to other baseline characteristics. The incidence of ADRs
was calculated and Pearson chi-square tests were used to evaluate
differences between categories. The Proportional hazard assumption was checked for all independent variables. A multivariable
Cox regression analysis was used to study the independent
association of variables with the presence of ADRs. The Relative
Risk (RR) with 95% Confidence Intervals (CIs) was estimated. In
the Cox model we adjusted for age, gender, employment status,
use of nonprescription medications at baseline as potential
confounding factors.
Statistical Package for Social Sciences (SPSS) Version 19 was
used for analysis.

Ascertainment of Polypharmacy
Trained interviewers screened and enrolled participants on the
basis of standard definition of Polypharmacy which is defined by
WHO as the, ‘‘concurrent use of five or more different
prescription medications [13].’’ Multiple sources like computerized
medical records, patient’s medical files and pharmacy prescriptions were used for data extraction to avoid any miss outs. The
unexposed group was defined as patients receiving less than five
drugs at their index visit. Telephonic interviews were conducted
once weekly till the sixth week by an interviewer to follow the
participants if they had developed any ADRs. At the index visit,
interviewer collected complete information related to dug history.
Subjects’ progress notes were also reviewed to determine any
information related to the addition of new drugs, newly developed
ADR’s, and critical laboratory values (see Appendix S1).

Results
We followed 1000 elderly patients for six weeks after
enrollment, and identified 107 (10.7%) ADRs in the full cohort.
The overall occurrence of ADRs due to polypharmacy was 70%.
Males were reported to have greater incidence of ADRs (59%).
We found slightly higher risks of ADRs among population of
illiterate persons when compared to people with higher level of
education. The hazard ratios for different levels of education status
ranged from 0.8–1.7. Likewise, use of non-prescription medicines,

Ascertainment of Adverse Drug Reaction
We obtained information on ADRs defined as ‘‘the presence of
undesired outcomes due to receiving medicines’’ from multiple
sources [14]. Two physicians and one pharmacist independently
reviewed each reported ADR to determine the likelihood that the
event was connected to a medication. A thorough literature search
PLOS ONE | www.plosone.org
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Figure 1. Flow of Study Participants.
doi:10.1371/journal.pone.0112133.g001

including herbal and homeopathic medicines, carries much higher
risk of ADRs. All other characteristics were comparable between
ADRs positive and ADRs negative groups as shown in table 1.
Later, we compared subjects according to exposure status
however; none of the characteristics were statistically different
between the two groups as shown in table 2.
After adjusting for age, gender and occupational status, an
adjusted multivariable model indicated that polypharmacy, low
level of education and use of concurrent homeopathic medicines
were significantly associated with ADRs among geriatrics. Risk of
ADRs among elderly patients with polypharmacy was 2.3 (95%
CI: 1.4–3.9) higher than those who took lesser number of
medicines. Low level of education (i.e. those who were unable to
read or write and those with less education than primary
schooling) was more likely to be associated with ADRs. However,
as the level of education increases the association with ADRs turns
out to be protective (RR = 0.7, 95% CI: 0.5–0.9). Risk of ADRs
among geriatrics who took concurrent homeopathic medicines was
higher compared to those who did not (RR = 7.4, 95% CI 3.2–
8.8), as shown in table 3.
In table 4, we calculated the incidence of ADRs according to
the exposure to various drug classes. The highest incidence was
found for antitussives and anti-dopaminergic drugs in our study
group.

PLOS ONE | www.plosone.org

Discussion
In this prospective cohort study the incidence of ADRs with
polypharmacy was found to be 10.5%, moreover, we also found
high rates of polypharmacy in geriatric outpatients which is
consistent with previous researches. In the current study, 68.2% of
the elderly patients were taking more than five medications a day.
This is slightly higher than the rates previously reported for
geriatric population. We observed a statistically significant
association between low levels of education and the concurrent
use of non-prescription medicines both before and after adjusting
for potential confounders. With the hope of directing intervention
efforts; many associations have been proposed for ADRs among
the geriatric population (aged 65 years or older) since they are
mostly prescribed with multiple medications which make them
vulnerable to ADRs.
Investigators suggest that longer stay in hospital is one of the
probable cause for the occurrence of ADRs in geriatrics and it is
defined as an undesirable condition caused by the use of multiple
medications [17].
The incidence of 10.6% ADRs found in this study is low as
compared to other general or outpatient studies conducted in
different countries [8,9,18]. This could be due to the difference in
the methodological aspects of the study particularly the study
population and the self-reporting of ADRs in the follow-ups which
was conducted through telephonic calls in the current study. This
3
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Table 1. Descriptive and Univariate Cox Analysis Along With 95% Confidence Intervals of Eligible Geriatrics Attending Tertiary Care
Center.

ADR Negative

ADR Positive

n = 893

n = 107

65–70

448 (50.2)

59 (55.1)

Reference

71–80

359 (40.2)

42 (39.3)

1.8

0.77–4.13

Above 80

86 (9.6)

6 (5.6)

1.6

0.68–3.77

Variable

*Unadjusted RR

95% CI

Age

Gender
Male

422 (47.3)

63 (58.9)

Reference

Female

471 (52.7)

44 (41.1)

1.5

1.03–2.2

Level of Education
More than 14 years

43 (4.8)

5 (4.7)

Reference

Can’t Read Or Write

269 (30.1)

36 (33.6)

1.7

1.3–2.8

Less than 5 years

119 (13.3)

25 (23.4)

1.6

1.3–4.3

6–14 years

462 (51.7)

41 (38.3)

0.8

0.2–0.9

Employed

421 (47.1)

45 (42.1)

Reference

Unemployed

472 (52.9)

62 (57.9)

1.2

No

877 (98.2)

94 (87.9)

Reference

Yes

16 (1.8)

13 (12.1)

4.6

No

873 (97.8)

95 (88.8)

Reference

Yes

20 (2.2)

12 (11.2)

3.8

No

278 (31.1)

18 (16.8)

Reference

Yes

615 (38.9)

89 (83.2)

2.1

Occupation

0.8–1.7

Use of Concurrent Homeopathic Medicine

2.5–8.2

Use of Concurrent Herbal Medicine

2.1–6.9

Poly-Pharmacy

1.2–3.4

*Relative risk obtained from Cox regression analysis.
doi:10.1371/journal.pone.0112133.t001

probably implies an underestimation of actual occurrence of
adverse effects. Another reason for the lower frequency of ADRs
observed in our study is probably due to the method of extracting
information on the use of complementary and alternative
medicines (herbal 3.2% and homeopathic 2.9%) which is missing
in most of the studies recording ADRs along with poly-pharmacy.
Interestingly, among these patients who were taking CAM, the
occurrence of ADRs were similar i.e. 12%. Most studies conclude
that most of the ADRs in outpatients turn out to be harmless;
however this study opposes this fact where 13% patients (n = 14
out of 107) had to make a hospital visit as a result of ADRs [19].
The use of CAM i.e. herbal and homeopathic has become
increasingly popular in both developed and the developing
countries [20,21]. In this study, 14% of the elderly patients were
using homeopathic and 13% were using herbal medications. This
is lower than the rates reported in other studies where the use of
CAM is as high as 66% [21]. One of the strong motivational
factors to use CAM is their perceived remedial benefits, and safety
profile. However, we can only speculate about the role and
benefits of CAM in certain diseases as the role of CAM in chronic
diseases is still controversial. In the current study those elderly who
were taking concurrent homeopathic medication were 7 times
more at risk of developing ADRs. The probable reason for this
high risk of developing ADRs can be due to the fact that many
commonly used CAM products have the potential to interfere with
PLOS ONE | www.plosone.org

the intended action of concomitant prescription medications,
which could lead to serious drug interactions and in turn increase
the risk of ADRs. Nevertheless, it is important to educate the
patients about the risks and benefits of CAM. Studies are required
to determine the impacts of CAM, particularly its impact when
used in conjunction with prescribed medicines.
It is evident that some drugs such as anticholinergic and
antipsychotics can impair the physical and cognitive function in
the elderly patients [22]. In the current study antipsychotics had
an ADR incidence of 333 per 1000 population and antihypertensive had incidence of 128/1000. This implies that the
more drugs with these effects that the elderly patients are exposed
to (number and dose), the poorer will be their quality of life and
they will be more prone to ADRs, as evident from the results of the
current study that those elderly patients who were positive of
polypharmacy had 2.3 times more risk of developing ADRs [23].
There are several strengths of our study; a cohort study design
was carefully chosen which is ideal in predicting the causal
association of exposure with the outcome so inferences can be
drawn regarding causality of association between polypharmacy
and other factors with the ADRs. We collected data from OPD
prescriptions to avoid any miss outs. In addition, we estimated the
incidence of ADRs due to polypharmacy, defined as the use of .5
scheduled medications in the line of WHO guidelines. The criteria
of more than five medications used included only systemic and
4
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Table 2. Characteristics of Eligible Participants Attending Tertiary Care Center, According To Exposure Status.

Polypharmacy (n) %

Variable

Yes

No

65–70

345 (49)

162 (54.7)

71–80

286 (40.6)

115 (38.9)

Above 80

73 (10.4)

19 (6.4)

Age

Level of Education
More than 14 years

35 (5)

13 (4.4)

Can’t Read or Write

221 (31.4)

84 (28.4)

Less than 5 years

103 (14.6)

41 (13.9)

6–14 years

345 (49)

158 (53.4)

Male

365 (51.8)

150 (50.7)

Female

339 (48.2)

146 (49.3)

No

686 (97.4)

282 (95.3)

Yes

18 (2.6)

14 (4.7)

No

691(98.2)

280 (94.6)

Yes

13 (1.8)

16 (5.4)

Gender

Use of Concurrent Herbal Medicine

Use of Concurrent Homeopathic Medicine

doi:10.1371/journal.pone.0112133.t002

drug effects, and prevalence of predisposing conditions that can
increase the frequency and severity of ADRs.
With the current state of health system utilization and healthseeking behavior in Pakistan, it is highly desirable to reduce the
divergence by exploring more opportunities for integration of
patient safety. As a way forward this study and its findings may
encourage the physicians to implement judicious prescribing.
Appropriate educational, managerial or regulatory strategies are
needed for evidence based prescribing. It is also important that
medications for the elderly patients be reviewed periodically for
indication, therapeutic aims, dose, efficacy and probable side
effects. Moreover, the benefit and risks of treatment (drugs)

routinely administered medications. Moreover, there was no loss
in following-up in our cohort. However, our study has certain
limitations that need to be considered while interpreting the
results. This was a hospital based study hence generalizability to
public sector settings remain questionable. We followed our
subjects for a duration of six weeks only, thus adverse effects
arising after this time may not be captured and this might have
underestimated our results.
To the best of our knowledge, this is the first Asian study to
record the incidence of ADRs in geriatric outpatients with
polypharmacy; our study confirms the notion that elderly patients
are more likely to experience these adverse reactions as the result
of age-related increase in the frequency of drug use, sensitivity to

Table 3. Adjusted Multivariable Analysis Showing Relative Risk of Adverse Drugs Reactions Along With 95% CI.

Variables

Relative Risk

95% CI

Polypharmacy
No

Reference

Yes

2.3

1.4–3.9

Level of Education
More than 14 years

Reference

Can’t Read Or Write

1.5

1.2–2.8

Less than 5 years

1.3

1.1–2.9

6–14 years

0.7

0.5–0.9

Use of Concurrent Homeopathic Medicine
No

Reference

Yes

7.4

3.2–8.8

doi:10.1371/journal.pone.0112133.t003

PLOS ONE | www.plosone.org
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Table 4. Incidence of Adverse Drug Reactions According To Drug Exposure.

Drugs Classification

ADR negative

ADR Positive

Incidence per 1000 population

Antitussives

1

2

666

Anti-dopaminergic

1

1

500

Antipsychotics

4

2

333

Anti-hypertensive

68

10

128

Antibiotics

98

14

125

Supplements

74

10

119

Cardiovascular

491

57

104

Anti-diabetics

73

6

75

Anti-lipidemic

13

1

71

NSAIDs

18

1

52

Anti-peptic ulcer

42

2

45

Statins

2

0

0

Anticoagulants

2

0

0

doi:10.1371/journal.pone.0112133.t004

including the impact on functions and quality of life should be
discussed with patients and their caregivers.
In conclusion, in this reasonably large hospital based prospective cohort study of geriatrics, the incidence of ADRs due to polypharmacy is high. Several factors including low level of education
and use of non-prescription medications remain responsible for the
high burden. While additional research with more sophisticated
design is needed to confirm our findings, our data suggests that a
comprehensive strategy for evidence based prescribing must be
implemented.

follow up phase, the patients were asked about self-medication and
its frequency, 53% patients were self-medicating via OTC drugs.
On asking whether a pharmacist provided them any valuable
information regarding side/adverse effects of the dispensed drug,
35% patients reported a negative response. The overall occurrence
of polypharmacy was 68% while the incidence of ADRs along with
polypharmacy was found to be 10.5%. About 3.2% of the
participants relied on herbal medicines and 3% on homeopathic
medicines.
Our study supports the findings of JK. Nguyen and colleagues.
Our Cox adjusted model shows that polypharmacy was 2.3 times
more associated with ADRs. Con-current homeopathic use was
7.4 times and those who were unable to read and write were 1.5
times more at risk of developing ADRs.

Research in Context
Stimulated by JK. Nguyen’s findings [9], we performed a
hospital based prospective cohort study where we surveyed the
geriatric population (.65 years) attending the outpatient clinics of
Aga Khan University Hospital Karachi throughout the year 2012.
The data was collected from different consulting clinics of
Anesthesia, Family Medicine, Internal Medicine and Obstetrics.
The sampled geriatric population was recruited from clinics and
followed to collect relevant factual data for the incidence of
adverse drug reactions due to polypharmacy. We used the
operational definition for polypharmacy as the concurrent use of
five or more different prescription medications.
We initiated the data collection by gathering demographic
information where 30% of the total patients were not able to read
or write and 53% of the patients were unemployed. The mean age
was found to be 70 years (range 65–70). Later on, during the
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